AOXING PHARMACEUTICAL COMPANY, INC.
DelistedCIK 1060426fmd_0Q49F6SW4QP16THSR1J0HSDK38Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2010 to Mar 31, 2017, 27 periods
| Line item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|
| Total revenues | 7 | 8 | 11 | 13 | 25 | 32 |
| Cost of revenue | 3 | 3 | 5 | 7 | 6 | 8 |
| Net interest income | (2) | (2) | (3) | (5) | (6) | (3) |
| Gross profit | 3 | 5 | 6 | 6 | 20 | 25 |
| Research and development | 1 | 1 | 1 | 1 | 0 | 3 |
| Total operating expenses | 8 | 19 | 20 | 9 | 11 | 18 |
| Operating income | (5) | (15) | (14) | (3) | 9 | 6 |
| Other non-operating income (expense) | 0 | (1) | – | – | – | – |
| Income before taxes | (4) | (16) | (17) | (9) | 3 | 3 |
| Income tax expense | 3 | – | – | – | (3) | 1 |
| Net income from continuing operations | (8) | – | – | – | 6 | 2 |
| Net income | (7) | (16) | (17) | (9) | 5 | 2 |